Azitra, Inc.
Azitra, Inc. (AZTR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AZTR · as of Jun 8, 2026
Key Statistics
Explore Azitra, Inc. Data
aztr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
aztr competitorsAZTR
ENVB
INDP
JSPR
LIPO
ONCOStock Performance
Full HistoryAbout Azitra, Inc.
Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biother…
what is azitra, inc. · aztr stock overview · azitra, inc. company profile · who is azitra, inc. ceo · aztr AMEX · azitra, inc. headquarters · azitra, inc. business segments
About Stock Overview & Key Data
Azitra, Inc. (AZTR) is a Healthcare company in the Biotechnology industry, listed on AMEX since Jun 20, 2023. As of the latest trading session, AZTR stock price is $0.20, with a market capitalization of $2.2M. The stock has returned -89.42% over the past 12 months and -22.87% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Azitra, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Azitra, Inc. reported revenue of — and net income of -$11.0M. For detailed data — including Azitra, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Azitra, Inc. (AZTR) stock price is $0.20. The stock is traded on AMEX under the ticker symbol AZTR. The 52-week range is $0.10 – $2.40.